Healthcare stocks on NSE
All 97 liquid NSE Healthcare stocks compared from their SEBI filings: market cap, trailing P/E (sector median 43.0), ROE, net margin and 1-year return. Medians: P/E 43.0, ROE 13.4%, net margin 12.2%, 1-year return +7.9%.
| Company | Symbol | Market cap | P/E | ROE | Net margin | 1 year |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹4,26,524 cr | 38.9 | 8.9% | 12.3% | +5.9% |
| Divi's Laboratories Limited | DIVISLAB | ₹2,59,170 cr | 88.6 | 21.5% | 29.3% | +47.7% |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹1,75,309 cr | 82.5 | 11.6% | 10.7% | +28.7% |
| Laurus Labs Limited | LAURUSLABS | ₹1,29,969 cr | 97.0 | 29.1% | 20.0% | +167.3% |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹1,24,301 cr | 27.5 | 13.9% | 11.7% | +26.1% |
| Apollo Hospitals Enterprise Limited | APOLLOHOSP | ₹1,21,482 cr | 58.1 | 24.5% | 8.2% | +6.9% |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,12,892 cr | 40.3 | 9.5% | 10.6% | +7.7% |
| Cipla Limited | CIPLA | ₹1,11,394 cr | 38.5 | 9.9% | 11.9% | -12.6% |
| Mankind Pharma Limited | MANKIND | ₹1,02,953 cr | 45.5 | 16.2% | 16.4% | +0.7% |
| Aurobindo Pharma Limited | AUROPHARMA | ₹96,748 cr | 26.1 | 10.9% | 11.3% | +52.7% |
| Lupin Limited | LUPIN | ₹91,953 cr | 16.6 | 25.2% | 17.1% | +3.7% |
| Max Healthcare Institute Limited | MAXHEALTH | ₹83,705 cr | 60.6 | 14.7% | 16.2% | -28.5% |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹64,869 cr | 43.4 | 18.4% | 12.0% | +23.5% |
| Alkem Laboratories Limited | ALKEM | ₹61,132 cr | 28.3 | 15.1% | 13.9% | -8.4% |
| Fortis Healthcare Limited | FORTIS | ₹57,992 cr | 55.3 | 10.8% | 10.5% | -29.2% |
| Biocon Limited | BIOCON | ₹57,329 cr | 115.8 | 1.7% | 3.3% | -1.2% |
| Gland Pharma Limited | GLAND | ₹51,070 cr | 45.2 | 12.2% | 17.6% | +59.8% |
| IPCA Laboratories Limited | IPCALAB | ₹48,908 cr | 37.3 | 19.9% | 14.4% | +49.9% |
| Anthem Biosciences Limited | ANTHEM | ₹46,755 cr | 81.2 | 15.8% | 28.7% | +9.5% |
| Ajanta Pharma Limited | AJANTPHARM | ₹43,983 cr | 34.8 | 32.0% | 21.6% | +43.9% |
| GlaxoSmithKline Pharmaceuticals Limited | GLAXO | ₹42,500 cr | 39.8 | 41.8% | 25.3% | -8.5% |
| Emcure Pharmaceuticals Limited | EMCURE | ₹35,395 cr | 35.0 | 23.8% | 11.4% | +38.5% |
| Aster DM Quality Care Limited | ASTERDM | ₹35,292 cr | 110.8 | 1.4% | 1.2% | -3.0% |
| Narayana Hrudayalaya Ltd. | NH | ₹35,124 cr | 40.9 | 24.1% | 10.6% | -2.1% |
| Global Health Limited | MEDANTA | ₹33,973 cr | 61.1 | 16.0% | 12.2% | -7.9% |
| Sai Life Sciences Limited | SAILIFE | ₹33,064 cr | 91.4 | 11.8% | 13.2% | +78.6% |
| Acutaas Chemicals Limited | ACUTAAS | ₹32,778 cr | 74.6 | 27.0% | 28.7% | +143.1% |
| Dr. Lal Path Labs Ltd. | LALPATHLAB | ₹31,965 cr | 59.0 | 27.0% | 21.3% | +22.7% |
| Piramal Pharma Limited | PPLPHARMA | ₹31,737 cr | — | 0.3% | 0.2% | +24.0% |
| Wockhardt Limited | WOCKPHARMA | ₹30,798 cr | 75.3 | 8.6% | 11.4% | +41.6% |
| Krishna Institute of Medical Sciences Limited | KIMS | ₹29,476 cr | 144.1 | 7.4% | 3.5% | -2.5% |
| Rubicon Research Limited | RUBICON | ₹26,634 cr | 92.4 | 26.3% | 15.9% | +160.3% |
| Neuland Laboratories Limited | NEULANDLAB | ₹25,285 cr | 63.1 | 31.5% | 23.0% | +20.4% |
| Granules India Limited | GRANULES | ₹20,809 cr | 31.4 | 14.2% | 12.2% | +47.4% |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹17,716 cr | 26.6 | 19.7% | 29.0% | +17.3% |
| Alivus Life Sciences Limited | ALIVUS | ₹17,376 cr | 25.9 | 21.7% | 28.9% | +53.3% |
| Cohance Lifesciences Limited | COHANCE | ₹16,999 cr | 160.0 | -2.5% | -5.7% | -50.1% |
| Pfizer Limited | PFIZER | ₹16,872 cr | 23.0 | 19.5% | 31.3% | -31.1% |
| Syngene International Limited | SYNGENE | ₹16,257 cr | 87.4 | 2.7% | 3.9% | -36.9% |
| Dr. Agarwal's Health Care Limited | AGARWALEYE | ₹16,142 cr | 108.8 | 8.9% | 7.4% | -6.7% |
| Eris Lifesciences Limited | ERIS | ₹16,039 cr | 22.7 | 17.7% | 20.6% | -27.6% |
| Alembic Pharmaceuticals Limited | APLLTD | ₹15,697 cr | 22.8 | 12.2% | 8.1% | -14.9% |
| Vijaya Diagnostic Centre Limited | VIJAYA | ₹14,767 cr | 78.8 | 22.2% | 23.0% | +44.7% |
| Poly Medicure Limited | POLYMED | ₹14,692 cr | 46.6 | 11.1% | 16.4% | -23.9% |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹14,624 cr | 41.5 | 3.2% | 2.5% | -14.3% |
| Indegene Limited | INDGN | ₹14,113 cr | 34.3 | 13.4% | 10.0% | +8.1% |
| Natco Pharma Limited | NATCOPHARM | ₹14,005 cr | 12.2 | 9.0% | 28.1% | -5.3% |
| Marksans Pharma Limited | MARKSANS | ₹13,876 cr | 26.9 | 20.8% | 18.7% | +72.9% |
| CORONA Remedies Limited | CORONA | ₹13,147 cr | 63.5 | 30.0% | 13.7% | — |
| Concord Biotech Limited | CONCORDBIO | ₹13,031 cr | 46.1 | 13.6% | 22.9% | -18.6% |
| Rainbow Childrens Medicare Limited | RAINBOW | ₹12,378 cr | 42.4 | 19.2% | 15.0% | -9.6% |
| Metropolis Healthcare Limited | METROPOLIS | ₹11,313 cr | 56.1 | 15.0% | 12.6% | +12.6% |
| Akums Drugs and Pharmaceuticals Limited | AKUMS | ₹11,253 cr | 38.6 | 12.1% | 8.6% | +59.2% |
| Strides Pharma Science Limited | STAR | ₹9,851 cr | 16.0 | 15.3% | 9.2% | +33.8% |
| Park Medi World Limited | PARKHOSPS | ₹9,541 cr | — | 16.3% | 17.3% | — |
| Viyash Scientific Limited | VIYASH | ₹9,540 cr | 55.7 | 9.1% | 7.0% | +7.9% |
| Procter & Gamble Health Limited | PGHL | ₹9,461 cr | 26.5 | 73.3% | 26.4% | -8.7% |
| Yatharth Hospital & Trauma Care Services Limited | YATHARTH | ₹8,931 cr | 51.2 | 10.4% | 12.0% | +14.3% |
| Blue Jet Healthcare Limited | BLUEJET | ₹8,752 cr | 37.3 | 23.0% | 26.7% | -22.8% |
| Healthcare Global Enterprises Limited | HCG | ₹8,734 cr | 383.4 | 4.1% | 2.0% | -20.3% |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹7,914 cr | 31.3 | 12.2% | 11.3% | +4.7% |
| Standard Engineering Technology Limited | SETL | ₹7,897 cr | 89.1 | 13.4% | 10.6% | +127.1% |
| Sanofi Consumer Healthcare India Limited | SANOFICONR | ₹7,825 cr | 28.0 | 88.1% | 29.1% | -27.4% |
| Sanofi India Limited | SANOFI | ₹7,369 cr | 20.2 | 56.5% | 23.7% | -31.5% |
| Thyrocare Technologies Limited | THYROCARE | ₹7,263 cr | 50.4 | 11.5% | 5.9% | +10.1% |
| Bliss GVS Pharma Limited | BLISSGVS | ₹6,929 cr | 43.0 | 16.2% | 16.7% | +328.5% |
| Supriya Lifescience Limited | SUPRIYA | ₹6,922 cr | 34.9 | 8.0% | 12.7% | +16.4% |
| Suven Life Sciences Limited | SUVEN | ₹6,851 cr | — | -86.3% | — | +35.5% |
| FDC Limited | FDC | ₹6,138 cr | 19.6 | 7.5% | 8.7% | -13.9% |
| Nephrocare Health Services Limited | NEPHROPLUS | ₹6,120 cr | — | 11.5% | 11.4% | — |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹5,726 cr | 3.6 | -6.2% | -52.0% | +36.4% |
| Senores Pharmaceuticals Limited | SENORES | ₹5,222 cr | 51.3 | 15.8% | 20.5% | +58.6% |
| IOL Chemicals and Pharmaceuticals Limited | IOLCP | ₹5,215 cr | 25.7 | 13.5% | 8.2% | +82.1% |
| Orchid Pharma Limited | ORCHPHARMA | ₹5,009 cr | 467.0 | 0.8% | 1.1% | +15.4% |
| SMS Pharmaceuticals Limited | SMSPHARMA | ₹4,789 cr | 46.6 | 10.6% | 10.1% | +74.5% |
| Artemis Medicare Services Limited | ARTEMISMED | ₹4,642 cr | 40.5 | 12.5% | 10.0% | +20.2% |
| Zota Health Care LImited | ZOTA | ₹4,585 cr | — | -16.4% | -12.8% | -13.0% |
| Aarti Drugs Limited | AARTIDRUGS | ₹3,972 cr | 20.8 | 13.0% | 7.1% | -15.9% |
| Ind-Swift Laboratories Limited | INDSWFTLAB | ₹3,202 cr | 38.3 | 9.3% | 14.2% | +263.3% |
| Solara Active Pharma Sciences Limited | SOLARA | ₹3,047 cr | 82.5 | 7.9% | 6.8% | +5.8% |
| Advanced Enzyme Technologies Limited | ADVENZYMES | ₹2,867 cr | 16.8 | 11.6% | 22.5% | -17.0% |
| Indraprastha Medical Corporation Limited | INDRAMEDCO | ₹2,802 cr | 14.6 | 26.3% | 13.0% | -45.1% |
| Hikal Limited | HIKAL | ₹2,613 cr | — | -2.5% | -1.8% | -11.8% |
| Sai Parenterals Limited | SAIPARENT | ₹2,284 cr | — | 6.5% | 4.4% | — |
| Dishman Carbogen Amcis Limited | DCAL | ₹2,274 cr | 140.7 | -3.5% | -8.5% | -47.9% |
| Sakar Healthcare Limited | SAKAR | ₹2,089 cr | 48.7 | 13.1% | 12.9% | +167.1% |
| Panacea Biotec Limited | PANACEABIO | ₹1,907 cr | — | 1.1% | 1.2% | -30.3% |
| Venus Remedies Limited | VENUSREM | ₹1,656 cr | 13.6 | 14.6% | 11.7% | +174.1% |
| Jagsonpal Pharmaceuticals Limited | JAGSNPHARM | ₹1,420 cr | 31.2 | 20.4% | 12.8% | -2.1% |
| Anlon Healthcare Limited | AHCL | ₹1,376 cr | 49.5 | 20.8% | 12.7% | +103.9% |
| Bajaj Healthcare Limited | BAJAJHCARE | ₹1,025 cr | 49.7 | 10.1% | 8.0% | -35.2% |
| Hexagon Nutrition Limited | HEXAGON | ₹665 cr | — | 13.8% | 7.7% | — |
| ABBOTT INDIA LIMITED | ABBOTINDIA | — | — | — | — | -13.6% |
| KWALITY PHARMACEUTICALS L | KPL | — | — | — | — | — |
| Onesource Specialty Pharma Limited | ONESOURCE | — | — | — | — | -14.6% |
| Shilpa Medicare Limited | SHILPAMED | — | — | — | 21.7% | +168.4% |
| SHUKRA PHARMACEUTICALS L | SHUKRAPHAR | — | — | — | — | — |
TRINETRA is a research and education tool. Nothing on this site is investment advice or a recommendation to buy or sell any security. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing. Figures are as filed with NSE/SEBI and as of the dates shown; they are not live prices.